Table 2 Incidence and categorization of AKI and its association with mortality after major abdominal surgery
From: Acute kidney injury in major abdominal surgery: incidence, risk factors, pathogenesis and outcomes
Study | Design | Setting | Criteria | AKI definition | N | Incidence | Mortality | AUROC |
|---|---|---|---|---|---|---|---|---|
Armstrong et al. [59] | Retrospective, single center | HBP | SCr | AKIN | 1535 | 5.10% 1–4.0% 2–0.8% 3–0.3% | 1.7% AKI versus 3.4% non-AKI, P = 0.21 | NA |
Bell et al. [58] | Interrupted time series analysis | MA/GI | SCr | KDIGO | 3271 | 9.80% | NA | NA |
Bihorac et al. [20] | Retrospective, single center | MA/GI | SCr | RIFLE | 2337 | 39.3% | NA | NA |
Biteker et al. [12] | Prospective, single center | MA/GI | SCr | RIFLE | 510 | 6.7% | 6.1% AKI versus 0.9% non-AKI, PÂ =Â 0.003 | NA |
Brunelli et al. (2012) | Retrospective, single center | MA/GI | SCr | AKIN/RIFLE | 1912 | 26.80% | NA | NA |
Causey et al. [32] | Retrospective, single center | Colorectal | SCr | RIFLE | 339 | 11.8% | 6.30% AKI versus 0.9%, PÂ =Â 0.065 | NA |
Chao et al. (2013) | Prospective, multicenter | MA/GI | SCr | AKIN | 4240 | 23.1% 1–13.7% 2–1.8% 3–7.6% | 28.40% 1–16% 2–29.7% 3–48.3% (HR 3.19, 95% CI 2.16–4.71; P < 0.001) | 0.728 |
Cho et al. [4] | Prospective, single center | HBP | SCr, UO | AKIN | 131 | 7.6% 1–3.8% 2–1.5% 3–2.3% | 7.10% AKI versus 2.5% non-AKI, P > 0.05 | NA |
Coca et al. [98] | Retrospective, multicenter | Non cardiac surgery | SCr | AKIN | 11.460 | 18.9% 1–5.2% 2–2.5% 3–1.2% | NA | NA |
Correa-Gallego et al. [60] | Retrospective, single center | HBP | SCr | RIFLE | 2166 | 15.5% R 12.8% I 2.3% F 0.4% | 1% AKI versus 2% non-AKI, PÂ =Â 0.5 | NA |
Grams et al. [89] | Retrospective, single center | MA/GI | SCr | KDIGO | 44.597 | 13.2% 1–9.4% 2–2.2% 3–1.5% | IRR 6.40 (95% CI, 5.75, 7.12) P < 0.05) | NA |
Kambakamba et al. [67] | Retrospective, single center | HBP | SCr | AKIN | 829 | 8.2% | 21% AKI versus 0.3% non-AKI, P  < 0.001 | 0.765 |
Kim et al. [68] | Retrospective, single center | UGI | SCr | KDIGO | 4718 | 14.4% 1–12.5% 2–1.3% 3–0.6% | 3.8% AKI versus 0.3% non-AKI, P < 0.001 (OR, 8.75; 95% CI, 3.98–19.27; P < 0.001) | NA |
Lee et al. [62] | Retrospective, single center | UGI | SCr | AKIN | 595 | 35.3% 1–30.3% 2–2.7% 3–4.2% | 4.80% AKI versus 2.1% non-AKI, P = 0.115 | NA |
Slankamenac et al. [64] | Retrospective, single center | HBP | SCr, UO | RIFLE | 569 | 15.1% | 22.5% AKI versus 0.8% non-AKI, PÂ <Â 0.001 | 0.75 |
Sun et al. [69] | Retrospective, single center | GYN | SCr | AKIN | 863 | 3.1% | NA | NA |
Sun et al. [69] | Retrospective, single center | MA/GI | SCr | AKIN | 1351 | 9.6% | NA | NA |
Teixeira et al. [8] | Retrospective, single center | MA/GI | SCr, UO | KDIGO | 450 | 22.4% 1–63.4% 2–19.8% 3–16.8% | 20.8% AKI versus 2.3% non-AKI, P < 0.001; OR 3.7, 95% CI 1.2–11.7, P = 0.024 | NA |
Tomozawa et al. [65] | Retrospective, single center | HBP | SCr | AKIN | 642 | 12.1% 1–9.8% 2–2.0% 3–0.3% | 14.1% AKI versus 2.3% non-AKI, P < 0.0001 | NA |
Vaught et al. [9] | Retrospective, single center | GYN | SCr | RIFLE | 2341 | 12.6% R–7.9% I–2.7% F–1.9% | 10% AKI versus 0.5% non-AKI, P < 0.0083 | 0.88 |